PURE Bioscience, Inc. is focused on developing and commercializing proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. PURE Bioscience technology platform is based on patented, stabilized ionic silver, and initial products contain Silver Dihydrogen Citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent that is manufactured as a liquid and delivered in various concentrations. The Company currently manufactures and distributes SDC-based disinfecting and sanitizing products, which are registered by the United States Environmental Protection Agency. PURE Bioscience also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products.

Type
Private
HQ
El Cajon, US
Founded
1992
Size (employees)
37 (est)
PURE Bioscience was founded in 1992 and is headquartered in El Cajon, US
Report incorrect company information

PURE Bioscience Office Locations

PURE Bioscience has an office in El Cajon
El Cajon, US (HQ)
1725 Gillespie Way
Show all (1)
Report incorrect company information

PURE Bioscience Financials and Metrics

Summary Metrics

Founding Date

1992

PURE Bioscience total Funding

$1.3 m

PURE Bioscience latest funding size

$1.27 m

Time since last funding

2 years ago
PURE Bioscience's latest funding round in May 2016 was reported to be $1.3 m. In total, PURE Bioscience has raised $1.3 m
Show all financial metrics

PURE Bioscience Revenue

USD

Net income (Q3, 2018)

(6.1 m)

EBIT (Q3, 2018)

(5.7 m)

Cash (30-Apr-2018)

1 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cost of goods sold

565 k344 k285 k441 k760 k

General and administrative expense

5.7 m5.1 m4.9 m5.1 m

R&D expense

1.3 m1 m790 k927 k

Operating expense total

7 m6.1 m5.7 m6 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cost of goods sold

45 k111 k65 k54 k48 k116 k265 k134 k132 k146 k307 k473 k

General and administrative expense

1.2 m1.2 m1.2 m1.1 m1.4 m1.4 m1.3 m1.3 m1.3 m1.4 m2.9 m4.1 m

R&D expense

176 k215 k171 k236 k238 k205 k248 k214 k222 k144 k264 k381 k

Operating expense total

1.4 m1.4 m1.4 m1.3 m1.6 m1.6 m1.6 m1.5 m1.5 m2.4 m4.8 m6.9 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

32 k86 k1.3 m5.2 m1.6 m

Accounts Receivable

18 k47 k189 k263 k297 k

Inventories

350 k27 k

Current Assets

486 k478 k2 m6.1 m2.5 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

5.3 m3.9 m2.5 m6.1 m6.7 m5.4 m4.1 m3.9 m2.7 m3.2 m2.1 m1 m

Accounts Receivable

47 k40 k86 k93 k106 k68 k146 k142 k185 k143 k146 k192 k

Inventories

231 k186 k207 k219 k237 k320 k348 k340 k348 k274 k267 k275 k

Current Assets

5.8 m4.2 m2.9 m6.6 m7.2 m6.2 m5 m4.6 m3.5 m3.9 m2.7 m1.6 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(7.7 m)(11.1 m)(7.6 m)(14.4 m)(6.3 m)

Depreciation and Amortization

311 k248 k219 k

Inventories

149 k(12 k)(143 k)27 k

Accounts Payable

560 k426 k
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(1.9 m)(1.7 m)(2.1 m)(2.8 m)(10.9 m)30 k(1.7 m)(936 k)(1.7 m)(2.3 m)(4.4 m)(6.1 m)

Depreciation and Amortization

71 k142 k213 k

Inventories

(1 k)(20 k)17 k

Accounts Payable

510 k510 k533 k384 k582 k522 k654 k424 k574 k(38 k)7 k(52 k)
USDY, 2018

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information

PURE Bioscience Online and Social Media Presence

Embed Graph
Report incorrect company information

PURE Bioscience News and Updates

Report incorrect company information

PURE Bioscience Company Life and Culture

Report incorrect company information